Koyfin Home > Directory > Health Care > Aeglea Biothera > EBIT

Aeglea Biothera EBIT Chart (AGLE)

Aeglea Biothera annual/quarterly EBIT from 2014 to 2020. Earnings before interest and taxes measures the profit a company generates from its operations, making it synonymous with operating profit. By ignoring tax and interest expenses, it focuses solely on a company's ability to generate earnings from operations, ignoring variables such as the tax burden and capital structure.
  • Aeglea Biothera EBIT for the quarter ending June 06, 2020 was $-22m a -2.72% increase of 1m year over year
  • Aeglea Biothera EBIT for the last 12 months ending June 06, 2020 was $-85m a 12.89% decrease of -11m year over year
  • Aeglea Biothera Annual EBIT for 2019 was $-80m a 43.41% decrease of -35m from 2018
  • Aeglea Biothera Annual EBIT for 2018 was $-45m a 39.12% decrease of -18m from 2017
  • Aeglea Biothera Annual EBIT for 2017 was $-28m a 20.85% decrease of -6m from 2016
Other Income Statement Metrics:
  • Aeglea Biothera EBITDA for the quarter ending December 12, 2018 was $-15m a 46.33% decrease of -7m year over year
  • Aeglea Biothera Net Income for the quarter ending December 12, 2018 was $-15m a 45.50% decrease of -7m year over year
  • Aeglea Biothera Total Revenue for the quarter ending June 06, 2018 was $2m a 46.97% increase of 1m year over year
View Chart On Koyfin

Quarterly AGLE EBIT Data

06/2020$-22m
03/2020$-19m
12/2019$-22m
09/2019$-22m
06/2019$-19m
03/2019$-18m
12/2018$-15m
09/2018$-12m
06/2018$-10m
03/2018$-8m

Annual AGLE EBIT Data

2019$-80m
2018$-45m
2017$-28m
2016$-22m
2015$-11m
2014$-9m
2013$-23m